PHS
JAZZ icon

PFM Health Sciences’s Jazz Pharmaceuticals JAZZ Stock Holding History

PFM Health Sciences’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.7M Buy
178,144
+127,633
+253% +$22.3M 3.07% 8
2025
Q4 		$8.59M Buy
+50,511
New +$7.74M 0.86% 36
2025
Q1 		– Sell
-17,597
Closed -$2.17M – 80
2024
Q4 		$2.17M Buy
+17,597
New +$2.07M 0.13% 70
2022
Q4 		– Sell
-571,936
Closed -$83.8M – 92
2022
Q3 		$76.2M Hold
571,936
– – 2.76% 7
2022
Q2 		$89.2M Buy
571,936
+55,530
+11% +$8.55M 3.4% 5
2022
Q1 		$80.4M Buy
+516,406
New +$74.9M 3.01% 9
2018
Q4 		– Sell
-958,025
Closed -$161M – 112
2018
Q3 		$161M Sell
958,025
-280,881
-23% -$48.3M 2.36% 5
2018
Q2 		$213M Buy
1,238,906
+103,379
+9% +$16.9M 3.34% 2
2018
Q1 		$171M Buy
+1,135,527
New +$167M 3.48% 4
2017
Q2 		– Sell
-864,276
Closed -$125M – 101
2017
Q1 		$125M Sell
864,276
-68,847
-7% -$8.97M 3.14% 2
2016
Q4 		$102M Sell
933,123
-228,179
-20% -$25.4M 2.87% 5
2016
Q3 		$141M Buy
1,161,302
+651,321
+128% +$87.8M 4.13% 2
2016
Q2 		$72.1M Sell
509,981
-254,403
-33% -$37.5M 2.17% 12
2016
Q1 		$99.8M Buy
764,384
+252,534
+49% +$31.4M 3.08% 8
2015
Q4 		$71.9M Buy
511,850
+185,848
+57% +$25.8M 2.19% 16
2015
Q3 		$43.3M Sell
326,002
-139,412
-30% -$24M 1.22% 30
2015
Q2 		$81.9M Sell
465,414
-59,589
-11% -$10.7M 2.07% 15
2015
Q1 		$90.7M Buy
+525,003
New +$90.1M 2.5% 9

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

PFM Health Sciences's JAZZ Position: Q1 2026 in Review

PFM Health Sciences increased its Jazz Pharmaceuticals (JAZZ) stake by 253% in Q1 2026, buying an estimated $22.3M and bringing the position to 178,144 shares worth $33.7M. The position accounts for 3.07% of the portfolio, ranked #8.

PFM Health Sciences first reported a position in JAZZ in Q1 2015 and has held it in 18 quarters since. The position peaked at $213M in Q2 2018. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • PFM Health Sciences held 178,144 shares of Jazz Pharmaceuticals worth $33.7M as of Q1 2026.
  • PFM Health Sciences bought 127,633 Jazz Pharmaceuticals shares in Q1 2026, an estimated $22.3M.
  • Jazz Pharmaceuticals made up 3.07% of PFM Health Sciences's portfolio in Q1 2026, its #8 holding.
  • PFM Health Sciences first reported a position in Jazz Pharmaceuticals in Q1 2015 and has held it in 18 quarters since.
  • PFM Health Sciences's Jazz Pharmaceuticals position peaked at $213M in Q2 2018.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.